As we all know, in the pharmaceutical industry, the production of preparations needs to be supported by the API links upstream of the industry chain. It can be seen that the large demand for liraglutide injection will inevitably drive the growth of the demand for its APIs. The liraglutide bulk drug

The rapid development of my country's Semaglutide intermediates industry began in 2000. At present, there are about 2,000 kinds of raw materials and intermediates needed for the chemical industry every year, and the demand is more than 2.5 million tons. Up to now, the chemical raw materials and inte

Diabetes is an increasingly serious global epidemic. As of 2015, 400 million adults worldwide are affected by diabetes, of which about 100 million are in China. Patients with type 2 diabetes are resistant to insulin or cannot secrete enough insulin to maintain normal blood sugar levels. Sustained hi

In the Semaglutide intermediates industry, in addition to directly cooperating with downstream customers to carry out contract customized production business, the most important business model is "R&D before sales". The characteristics of competition in the industry can be summarized as access quali